Hui K - Search Results

1

AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.

Wang B, Gu Y, Hui K, Huang J, Xu S, Wu S, Li L, Fan J, Wang X, Hsieh JT, He D, Wu K. Wang B, et al. Among authors: hui k. Urol Oncol. 2018 Oct;36(10):472.e11-472.e20. doi: 10.1016/j.urolonc.2018.07.005. Epub 2018 Aug 20. Urol Oncol. 2018. PMID: 30139661

2

miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.

Huang J, Wang B, Hui K, Zeng J, Fan J, Wang X, Hsieh JT, He D, Wu K. Huang J, et al. Among authors: hui k. Oncol Rep. 2016 Sep;36(3):1693-701. doi: 10.3892/or.2016.4940. Epub 2016 Jul 15. Oncol Rep. 2016. PMID: 27430302

3

DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.

Wang B, Huang J, Zhou J, Hui K, Xu S, Fan J, Li L, Wang X, Hsieh JT, He D, Wu K. Wang B, et al. Among authors: hui k. Cell Signal. 2016 Nov;28(11):1623-30. doi: 10.1016/j.cellsig.2016.07.011. Epub 2016 Jul 27. Cell Signal. 2016. PMID: 27476001

4

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.

Hui K, Gao Y, Huang J, Xu S, Wang B, Zeng J, Fan J, Wang X, Yue Y, Wu S, Hsieh JT, He D, Wu K. Hui K, et al. Cell Death Dis. 2017 Feb 9;8(2):e2600. doi: 10.1038/cddis.2017.9. Cell Death Dis. 2017. PMID: 28182001 Free PMC article.

5

RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.

Hui K, Wu S, Yue Y, Gu Y, Guan B, Wang X, Hsieh JT, Chang LS, He D, Wu K. Hui K, et al. Cell Signal. 2018 Aug;48:38-44. doi: 10.1016/j.cellsig.2018.04.006. Epub 2018 Apr 24. Cell Signal. 2018. PMID: 29702203

6

2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.

Wu S, Huang J, Hui K, Yue Y, Gu Y, Ning Z, Wang X, He D, Wu K. Wu S, et al. Among authors: hui k. Oncol Rep. 2018 Nov;40(5):2836-2843. doi: 10.3892/or.2018.6678. Epub 2018 Aug 31. Oncol Rep. 2018. PMID: 30226607

7

MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma.

Yue Y, Hui K, Wu S, Zhang M, Que T, Gu Y, Wang X, Wu K, Fan J. Yue Y, et al. Among authors: hui k. Cell Death Dis. 2020 May 7;11(5):336. doi: 10.1038/s41419-020-2518-9. Cell Death Dis. 2020. PMID: 32382053 Free PMC article.

8

DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling.

Wu K, Wang B, Chen Y, Zhou J, Huang J, Hui K, Zeng J, Zhu J, Zhang K, Li L, Guo P, Wang X, Hsieh JT, He D, Fan J. Wu K, et al. Among authors: hui k. Cell Signal. 2015 Dec;27(12):2515-23. doi: 10.1016/j.cellsig.2015.09.014. Epub 2015 Sep 26. Cell Signal. 2015. PMID: 26410305

9

Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.

Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q, Xu S, Jia J, Tang X, Li F, Hui K, He D, Guo P. Gao Y, et al. Among authors: hui k. Oncotarget. 2015 Dec 22;6(41):43791-805. doi: 10.18632/oncotarget.6101. Oncotarget. 2015. PMID: 26544730 Free PMC article.

10

KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFα in LNCaP prostate cancer cells.

Shi Q, Jia J, Hui K, Gao Y, Xu S, Guan B, Tang X, Wang X, He D, Guo P. Shi Q, et al. Among authors: hui k. Oncol Lett. 2017 Aug;14(2):1847-1854. doi: 10.3892/ol.2017.6293. Epub 2017 Jun 1. Oncol Lett. 2017. PMID: 28789420 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,014 results

Search Page

Filters